Genis is an innovative Icelandic biotechnology brand that is leading the way in the development of therapeutic chitin derivatives. With a talented team of experienced directors and a dedicated management team, Genis is committed to pushing the boundaries of life science. Under the guidance of Róbert Guðfinnsson, the Chairman of the board, alongside fellow board members Gunnhildur Róbertsdóttir, Jón S.

Árnason, Sigþór Sigmarsson, and Hrafn Árnason, Genis is driven by a strong collaborative spirit and a commitment to excellence. The knowledgeable management team is led by Sigurgeir Gudlaugsson, the Chief Executive Officer, and supported by experts such as Ph. D.

Thorlakur Jonsson, the Chief Scientific Officer, and Gudmundur K. Jonsson, the Chief Commercial Officer, in addition to a team of skilled scientists and project managers. Genis is motivated by a passion for science and regulatory compliance, ensuring the production of high-quality products.

With a focus on therapeutics and tissue regeneration, Genis is at the forefront of biotechnology, revolutionizing the field with their groundbreaking research. Contact them at their headquarters in Siglufjordur, Iceland, to learn more about their cutting-edge solutions